- $2.36bn
- $2.60bn
- $1.36bn
- 84
- 66
- 56
- 77
R2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,050 | 1,159 | 1,417 | 1,391 | 1,364 |
Cost of Revenue | |||||
Gross Profit | 863 | 980 | 1,229 | 1,195 | 1,167 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 962 | 1,003 | 1,276 | 1,181 | 1,231 |
Operating Profit | 88.2 | 155 | 140 | 210 | 133 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 54.8 | 78.3 | 351 | 131 | 75 |
Provision for Income Taxes | |||||
Net Income After Taxes | 41.1 | 40 | 366 | 73.2 | 50.8 |
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 219 | 151 | 497 | 63.8 | 41.5 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 218 | 151 | 496 | 63.7 | 41.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.831 | 0.43 | 9.55 | 1.58 | 1.72 |
Dividends per Share |